Rankings
▼
Calendar
DSGN FY 2023 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DSGN
Design Therapeutics, Inc.
$569M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$537,000
Operating Income
-$78M
Net Income
-$67M
EPS (Diluted)
$-1.19
Cash Flow
Operating Cash Flow
-$59M
Free Cash Flow
-$59M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$290M
Total Liabilities
$12M
Stockholders' Equity
$278M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$537,000
-$466,000
-15.2%
Operating Income
-$78M
-$68M
-15.7%
Net Income
-$67M
-$63M
-5.6%
← Q4 2022
All Quarters
Q1 2023 →